Clinical Trials
33 trialsSTBETA
University Hospital, Bordeaux
COCOON
Janssen Research & Development, LLC
Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study
Sun Yat-sen University
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Washington University School of Medicine
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
Emory University
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Emory University
Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
GPCR Therapeutics, Inc.
A Study of Propranolol to Treat Kaposi Sarcoma
AIDS Malignancy Consortium
OC-POP-PT
Tel-Aviv Sourasky Medical Center
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
AHS Cancer Control Alberta
Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Wake Forest University Health Sciences
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
Huashan Hospital
PeP-RALP
Oslo University Hospital
METRO-NB2012
University of Cologne
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
St. Joseph's Hospital and Medical Center, Phoenix
IMPULS
Zealand University Hospital
Propranolol in Angiosarcoma
The Netherlands Cancer Institute
PROPANE
Herlev and Gentofte Hospital
Treat_CCM
Mario Negri Institute for Pharmacological Research
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Columbia University
Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients
Medical College of Wisconsin
Propranolol Adjuvant Treatment of Bladder Cancer
Central South University
Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer
Central South University
BC-PC
Assaf-Harofeh Medical Center
Efficacy of Propranolol Treatment to Prevent Melanoma Progression
University Hospital, Geneva
COMPIT-2
Assaf-Harofeh Medical Center
Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma
Military Institute od Medicine National Research Institute
Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)
Seattle Children's Hospital
Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer
Vicus Therapeutics
NPBC
Texas Tech University Health Sciences Center, El Paso
Bevacizumab vs Dacarbazine in Metastatic Melanoma
Haukeland University Hospital
Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas
Children's National Research Institute
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
University of Sao Paulo